secwatch.observer — SEC 8-K summary
======================================

Issuer:     Anika Therapeutics, Inc. (ANIK)
CIK:        0000898437
Form:       8-K
Filed at:   2024-07-11T23:59:59+00:00
Accession:  0001171843-24-003900
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Anika Therapeutics stockholders elect directors and ratify auditor at 2024 annual meeting
--------------------------------------------------------------------------------

- Elected Sheryl L. Conley, William R. Jellison, Stephen O. Richard as Class I directors (2027 term).
- Ratified Deloitte & Touche LLP as independent auditor: 12,337,376 for, 43,654 against.
- Say-on-pay proposal passed on a non-binding advisory basis: 11,020,273 for, 129,717 against.
- Annual meeting turnout: 12,387,064 shares voted, representing 83.37% of entitled voting power.
- No contested solicitations; all board proposals carried with substantial majority support.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/898437/000117184324003900/0001171843-24-003900-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/898437/000117184324003900/f8k_071124.htm
  HTML page:      https://secwatch.observer/filing/0001171843-24-003900

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer